Rapid Oral Fluid Screening Device Market Size Worth $24.08 Billion By 2027 | CAGR: 20.7%

The global rapid oral fluid screening device market size is predicted to reach USD 24.08 billion by 2027 according to a new study by Polaris Market Research. The report “Rapid Oral Fluid Screening Device Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Alcohol, Marijuana, Opioids, Cocaine, Amphetamine, Methamphetamine, Benzodiazepines); By Forms (Cassettes, Swabs, Strips); By End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Private Employers, Home care Setting); By Regions; Segment Forecast, 2020 - 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

In trend with the developing business models in healthcare sector, development of effective, efficient and productive products is on a significant surge, coupling with increasing favorable reimbursements and approvals by the government. Rising strong product pipelines for the research & development of novel rapid oral fluid screening devices also contribute a remarkable proportion towards surging the market growth globally over the forecast period.

Furthermore, as the technology is becoming easy-to-develop and subject to a smaller number of regulations, the market is witnessing less entry hurdles for new entrants. Additionally, rapid oral fluid has ability to diagnose drug consumed in the body in less than one day and cannabis consumed in less than four hours after the testing time, hence, propelling the growth of rapid oral fluid screening devices, globally over the projected period.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link: https://www.polarismarketresearch.com/industry-analysis/rapid-oral-fluid-screening-device-market/request-for-sample

Rapid oral fluid screening devices provide a wide range of screening abilities such as marijuana, cocaine, methamphetamine, and opioids are expected to drive rapid oral fluid screening device market growth over the forecast period. In addition, the growing need for drug screening across the regions owing to increasing consumption of illegal narcotics is expected to drive the demand for these devices in the coming years.

The global rapid oral fluid screening device market players include OraSure Technologies, Inc., Oranoxis Inc., Guangzhou Wondfo Biotech Co., Ltd, UCP Biosciences, Inc., MEDACX Limited, Screen Italia Srl, and AccuBioTech Co. Ltd., among others. Moreover, developing and commercializing products that evaluate adherence to HIV medications, enhancing its product offerings to include additional diagnostic offerings, and building new infrastructure also adds towards the growth of the organizations.

Polaris Market Research has segmented the rapid oral fluid screening device market report on the basis of drug type, form, end-use, and region

Global Rapid Oral Fluid Screening Device Market, By Drug Type (Revenue - USD Million, 2016 – 2027)

• Alcohol
• Marijuana
• Opioids
• Cocaine
• Amphetamine
• Methamphetamine
• Benzodiazepines
• Others

Global Rapid Oral Fluid Screening Device Market, By Form (Revenue - USD Million, 2016 – 2027)

• Cassettes
• Swabs
• Strips

Global Rapid Oral Fluid Screening Device Market, By End-Use (Revenue - USD Million, 2016 – 2027)

• Hospital
• Diagnostic Laboratories
• Forensic Laboratories
• Private Employers
• Home Care Setting

Rapid Oral Fluid Screening Device Market Regional Outlook (Revenue - USD Million, 2016 – 2027)

• North America
  • U.S.
  • Canada
• Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
• Central & South America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa